Immunodiagnostic Systems Holdings plc (“IDS” or ‘”the Company”) announces that it has received USA FDA (Food and Drug Administration) clearance for its Direct Renin assay for use on its IDS-iSYS system, enabling IDS to enter the US market with this product. The IDS-iSYS Direct Renin immunoassay is used to determine the amount of active renin […]
The IDS-iSYS Immunoassay System merges 50 years of instrumentation experience with our world-class assays into a compact, fully automated system. It now offers 22 new automated assays within 5 autoimmune disease areas (Connective Tissue, Rheumatoid Arthritis, Gastrointestinal, Phospholipids and Vasculitis) on its well established IDS-iSYS system. Visit us at Stand 03 to find out more […]
